The Lockwood Group, LLC

Scientific Director - Publications

United States

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Biotech, Medical Device, Medical CommunicationsIndustries

Requirements

An advanced degree in science (PhD, PharmD, or MD) is required, with CMPP preferred. Candidates must possess 5 or more years of relevant job experience in medical publications, including manuscripts, posters, abstracts, podium presentations, scientific platforms, and publication extenders. Demonstrated organizational, analytical, and interpersonal communication skills are necessary, along with the ability to analyze and interpret scientific data, multitask, work independently, and manage projects within tight deadlines. Experience with established professional medical editorial processes (AMA style) and working knowledge of ethical guidelines (ICMJE, GPP2022) is also required. Experience with oncology, notably CAR-T, is preferred.

Responsibilities

The Scientific Director is responsible for the planning, development, and oversight of scientific content for assigned accounts across various therapeutic areas and target audiences. Responsibilities include working with the Group Scientific Director to provide clients with strategic medical communication recommendations that support brand goals, independently leading the execution of content development activities, supervising Associate Scientific Directors, and liaising with other in-house or freelance staff to manage writing and other content-related tasks such as conducting background research, data-checking, and reference annotation.

Skills

Medical Publications
Manuscripts
Posters
Abstracts
Podium Presentations
Scientific Content Development
Medical Communications
Research
Data Checking
Reference Annotation
Strategic Planning
Team Leadership

The Lockwood Group, LLC

Healthcare consulting for drug development support

About The Lockwood Group, LLC

The Lockwood Group provides consulting services specifically for the healthcare and pharmaceutical industries, focusing on clients in the later stages of drug development, particularly after Phase 2 clinical trials. The company assists pharmaceutical and biotech firms by creating strategic publication plans that communicate scientific data and research findings accurately and in compliance with regulatory standards. They also support clients during the prelaunch phase of their products by identifying market needs and collaborating through the launch process to ensure success. A unique aspect of The Lockwood Group is its medical animation affiliate, Random42, which produces engaging and scientifically accurate visual content to help convey complex information. Their business model is based on service fees for consulting and project work, with a commitment to delivering high-quality communications and strategic support to help clients thrive in the competitive healthcare landscape.

Stamford, ConnecticutHeadquarters
2007Year Founded
ACQUISITIONCompany Stage
Consulting, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options
Flexible Work Hours

Risks

Emerging firms using AI-driven content creation threaten market share.
Pharmaceutical companies developing in-house teams may reduce demand for external services.
Tightening EU regulatory standards could increase compliance costs.

Differentiation

Specializes in healthcare and pharmaceutical sectors, focusing on advanced drug development stages.
Offers strategic publication plans tailored to specific audiences and regulatory standards.
Provides commercial support during prelaunch, launch, and post-launch phases.

Upsides

Increased demand for digital health solutions boosts growth in medical communications.
Rise of personalized medicine creates opportunities for specialized communication strategies.
Integration of AI enhances publication strategies and data analysis capabilities.

Land your dream remote job 3x faster with AI